HARIGAI Masayoshi | The Ad Hoc Committee for the Safety of Biological DMARDs, Japan College of Rheumatology

スポンサーリンク

概要

関連著者

Miyasaka Nobuyuki
Global Center Of Excellence (gcoe) Program Department Of Medicine And Rheumatology Graduate School O
KOIKE Takao
Sapporo Medical Center NTT EC
MIYASAKA Nobuyuki
Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo Medical and Dental University
TAKAMURA Akito
The Ad Hoc Committee for the Safety of Biological DMARDs, Japan College of Rheumatology
SETO Yohei
The Ad Hoc Committee for the Safety of Biological DMARDs, Japan College of Rheumatology
KAMEDA Hideto
The Ad Hoc Committee for the Safety of Biological DMARDs, Japan College of Rheumatology
NAGASAWA Hayato
The Ad Hoc Committee for the Safety of Biological DMARDs, Japan College of Rheumatology
HARIGAI Masayoshi
The Ad Hoc Committee for the Safety of Biological DMARDs, Japan College of Rheumatology
ATSUMI Tatsuya
The Ad Hoc Committee for the Safety of Biological DMARDs, Japan College of Rheumatology
DOHI Makoto
The Ad Hoc Committee for the Safety of Biological DMARDs, Japan College of Rheumatology
HIRATA Shintaro
The Ad Hoc Committee for the Safety of Biological DMARDs, Japan College of Rheumatology

もっと見る

著作論文

Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis : a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs

スポンサーリンク